Valsartan

Valsartan is a substituted imidazole derivative featuring a biphenyl-tetrazole core linked via a methylene bridge to an imidazole ring, with a 4-chlorophenyl substituent and a 2-butyl chain. The tetrazole moiety (1H-tetrazol-5-yl) at the biphenyl terminus confers high receptor affinity, while the chloro substitution enhances metabolic stability. This angiotensin II receptor antagonist functions as the parent API for antihypertensive formulations. Its rigid aromatic framework and hydrogen-bonding tetrazole group are critical for AT1 receptor binding. Analytically, it serves as an HPLC reference standard for quality control of cardiovascular drug products.